News-Papers
Testimonial
Video Gallery
 | |||||
 |  |  |  |  |  |
Search
Follow us...
Latest
- Melatonin: an inhibitor of breast cancer
- All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma
- Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice
- Effect of oral melatonin on sleep quality, fatigue, and caregiver sleep perception in patients with head and neck cancer: A randomized double-blind placebo-controlled trial
- Mechanisms Underlying Tumor Suppressive Properties of Melatonin
- Vitamin D supplementation is associated with reduced risk of hepatobiliary malignancy in patients with primary sclerosing cholangitis
- Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells
- A case control study to determine the frequency of vitamin d deficiency in carcinoma breast in females of local population of Rawalpindi and Islamabad area
- In vitro and in vivo antitumor activity of melatonin receptor agonists
- Proteoformics-driven new concept of human growth hormone in clinical endocrinology
- The role of melatonin in colorectal cancer treatment: a comprehensive review
- The Role of Melatonin in Colorectal Cancer
- Ameliorative effects of melatonin on radiotherapy-induced apoptotic and inflammatory responses in rat parotid gland
- The role of melatonin in immuno-enhancement: potential application in cancer
- Circulating neuroendocrine markers in patients with prostate carcinoma
- Somatostatin and the treatment of cancer
- Somatostatin and analogues in the treatment of cancer. A review
- Somatostatin analogues in the treatment of breast and prostate cancer
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer